![]() |
Re: Coronavirus
Quote:
|
Re: Coronavirus
It was reported to me about a risk of pericarditis for pacemaker users receiving Pfizer booster but a brief google can't find exact details other than a known side effect on some younger males. I am male and while I like to think of myself as "younger" I really don't fit into that category any more.
|
Re: Coronavirus
Still have a slightly sore arm from Saturday's booster but that's it.
|
Re: Coronavirus
Quote:
Lots of info on the subject if you dig about here: https://www.youtube.com/c/Campbellte...y=pericarditis Quote:
|
Re: Coronavirus
The idiots are at it again.
Quote:
|
Re: Coronavirus
Quote:
|
Re: Coronavirus
Quote:
|
Re: Coronavirus
OK . . who's bought shares in the vaccine manufacturers?
Looks like a better return than Bitcoin if Covid is here to stay :erm: |
Re: Coronavirus
Quote:
This assumes no new variants that are of sufficient concern to take further vaccination measures. |
Re: Coronavirus
Quote:
|
Re: Coronavirus
Quote:
Plans are afoot for annual vaccinations. Given efficacy for the first two rapidly declines after six months there's no reason to expect a third to provide infinite immunity. |
Re: Coronavirus
Quote:
I agree, it'll be an annual vaccination just like the flu jab. |
Re: Coronavirus
Quote:
---------- Post added at 17:31 ---------- Previous post was at 17:29 ---------- Quote:
|
Re: Coronavirus
Quote:
|
Re: Coronavirus
Quote:
This article touches on it, but is not optimistic that this can be achieved in the short term. But as yet, we don’t know for sure. With the vaccinations protecting us, there will no longer be drastic consequences due to natural infection or re infection, so you could rely on that to avoid the need for constant re-vaccinations. [EXTRACT FROM British Medical Journal] Antibodies and reinfection Over time covid-19 could become a disease first encountered in early childhood, when it would typically cause mild infection or none at all, Jennie Lavine, an infectious disease researcher at Emory University in Atlanta, USA, told Nature. Although that defence would wane quickly and not be sufficient to block reinfection entirely, it could be enough to protect adults experiencing severe symptoms. Scientists consider this scenario likely because it matches four existing endemic coronaviruses—OC43, 229E, NL63, and HKU1—but it is not certain. A large study has shown that levels of neutralising antibodies start to decline after around six to eight months after infection with SARS-CoV-2.2 If a new infection arises, memory B cells can manufacture antibodies and T cells that can eliminate virus infected cells, but it has yet to be established whether this immune memory can block viral reinfection. |
All times are GMT +1. The time now is 01:39. |
Powered by vBulletin® Version 3.8.11
Copyright ©2000 - 2025, vBulletin Solutions Inc.
All Posts and Content are © Cable Forum